A clinical study of Manadha Gutika and Vasadi Kwath in the management of Yakrit Vikar w.s.r. to Fatty Liver
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Changes in USG, LFT and Lipid Profile Findings
研究概览
简要总结
Fatty liver is no longer strange to us especially now-a-days in the society. Fatty liver refers as the accumulation of fat in the liver that can cause inflammation and gradually decrease in liver function. Fatty liver is a metabolic disorder. Fatty liver is an important cause of chronic liver disease and should be treated in early condition. Liver disorder one of the major problems and it is among the top ten cause of death in the world.According to the latest WHO data published in 2020 liver disease deaths in India reached 268,580 or 3.17% of total deaths. The prevalence of fatty liver in India is 9-32% with an average of 25% in general population. The holistic concepts of Ayurveda give emphasis to health promotion, disease prevention, early diagnosis and personalized treatment even in Liver care**.** Ayurvedic preparation Manadha Gutika and Vasadi Kwath is adopted for the treatment of fatty Liver**.**
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients presenting with classical sign & symptoms as described in Ayurvedic and Modern medicine.
- •Patients willing to sign the consent form.
- •Abnormal Liver Function Tests.
- •Both sex groups randomly selected and patient with history of Fatty Liver less than 1year.
- •USG findings suggestive of fatty liver grade 1 and grade 2.
排除标准
- •Patient below 18 year and above 60 years of age group & Pregnant females.
- •Patient having chronic heart disease, chronic renal failure, hepatocellular or any other carcinoma, tuberculosis, portal vein obstruction, biliary obstruction, ascitise.
- •Alcoholic fatty liver disease, any infective liver disorder, hypertension, diabetes mellitus and any surgery.
- •Drug addicts’ rapid deterioration, who lapsed into coma and bleeding tendencies.
- •Patients consuming hepatotoxic medicines, Alcohol or other Narcotic substances.
结局指标
主要结局
Changes in USG, LFT and Lipid Profile Findings
时间窗: 60 Days
次要结局
- Changes in Symptoms likes DAURBALYA (WEAKNESS)(AROCHAK (LACK OF APPETITE))
研究者
Dr Abhishek Kumar Tyagi
Govt Dhanwantri Ayurved Medical College And Hospital Ujjain Madhyapradesh